Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 13, 2013, Pages 5097-5102

  Paduraru, Crina ^a,b   Bezbradica, Jelena S ^a,b   Kunte, Amit ^a,b   Kelly, Robert ^c   Shayman, James A ^c   Veerapen, Natacha ^d   Cox, Liam R ^d   Besra, Gurdyal S ^d   Cresswell, Peter ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Antigen processing; Lipid storage disease

Indexed keywords

CD1D ANTIGEN; LYSOSOMAL PHOSPHOLIPASE A2; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CELL COUNT; CELL MATURATION; INVARIANT NATURAL KILLER T CELL; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACYLTRANSFERASES; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD1D; LYMPHOCYTE COUNT; LYSOSOMES; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; PHOSPHOLIPASES A2; THYMUS GLAND;

MUS;

EID: 84875518070     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1302923110     Document Type: Article

References (74)

1. Barral DC, Brenner MB (2007) CD1 antigen presentation: How it works. Nat Rev Immunol 7(12):929-941.
2. Issazadeh-Navikas S (2012) NKT cell self-reactivity: Evolutionary master key of immune homeostasis? J Mol Cell Biol 4(2):70-78.
3. Terabe M, Berzofsky JA (2008) The role of NKT cells in tumor immunity. Adv Cancer Res 101:277-348.
4. Cohen NR, Garg S, Brenner MB (2009) Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol 102:1-94.
5. Lantz O, Bendelac A (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180(3):1097-1106.
6. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A (1994) An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med 180(3):1171-1176.
7. Brossay L, et al. (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188(8):1521-1528.
8. Porcelli S, Yockey CE, Brenner MB, Balk SP (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J ExpMed 178(1):1-16.
9. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI (2012) Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol 12(12):845-857.
10. Arrenberg P, Halder R, Dai Y, Maricic I, Kumar V (2010) Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked selfglycolipid. Proc Natl Acad Sci USA 107(24):10984-10989.
11. Rhost S, Sedimbi S, Kadri N, Cardell SL (2012) Immunomodulatory type II natural killer T lymphocytes in health and disease. Scand J Immunol 76(3):246-255.
12. Park SH, et al. (2001) The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med 193(8):893-904.
13. Behar SM, Podrebarac TA, Roy CJ, Wang CR, Brenner MB (1999) Diverse TCRs recognize murine CD1. J Immunol 162(1):161-167.
14. Gapin L, Matsuda JL, Surh CD, Kronenberg M (2001) NKT cells derive from doublepositive thymocytes that are positively selected by CD1d. Nat Immunol 2(10):971-978.
15. Coles MC, Raulet DH (2000) NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol 164(5): 2412-2418.
16. Chun T, et al. (2003) CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med 197(7):907-918.
17. Dao T, et al. (2004) Development of CD1d-restricted NKT cells in the mouse thymus. Eur J Immunol 34(12):3542-3552.
18. Wei DG, et al. (2005) Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med 202(2):239-248.
19. Schümann J, et al. (2005) Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells. J Immunol 175(11):7303-7310.
20. Pellicci DG, et al. (2002) A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med 195(7):835-844.
21. Egawa T, et al. (2005) Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22(6):705-716.
22. Bezbradica JS, Hill T, Stanic AK, Van Kaer L, Joyce S (2005) Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. Proc Natl Acad Sci USA 102(14):5114-5119.
23. Das R, Sant'Angelo DB, Nichols KE (2010) Transcriptional control of invariant NKT cell development. Immunol Rev 238(1):195-215.
24. Hu T, Gimferrer I, Alberola-Ila J (2011) Control of early stages in invariant natural killer T-cell development. Immunology 134(1):1-7.
25. Godfrey DI, Stankovic S, Baxter AG (2010) Raising the NKT cell family. Nat Immunol 11(3):197-206.
26. Engel I, Kronenberg M (2012) Making memory at birth: Understanding the differentiation of natural killer T cells. Curr Opin Immunol 24(2):184-190.
27. Zhou D, et al. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306(5702):1786-1789.
28. Porubsky S, et al. (2012) Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells. J Immunol 189(6):3007-3017.
29. Porubsky S, et al. (2007) Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci USA 104(14):5977-5982.
30. Facciotti F, et al. (2012) Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol 13(5):474-480.
31. Kang SJ, Cresswell P (2004) Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 5(2):175-181.
32. Zhou D, et al. (2004) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303(5657):523-527.
33. Yuan W, et al. (2007) Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc Natl Acad Sci USA 104(13):5551-5556.
34. Schrantz N, et al. (2007) The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J ExpMed 204(4): 841-852.
35. Facciotti F, et al. (2011) Fine tuning by human CD1e of lipid-specific immune responses. Proc Natl Acad Sci USA 108(34):14228-14233.
36. Brozovic S, et al. (2004) CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med 10(5):535-539.
37. Dougan SK, et al. (2005) Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med 202(4):529-539.
38. Dougan SK, Rava P, Hussain MM, Blumberg RS (2007) MTP regulated by an alternate promoter is essential for NKT cell development. J Exp Med 204(3):533-545.
39. Sagiv Y, et al. (2007) A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d. J Exp Med 204(4):921-928.
40. Yuan W, Kang SJ, Evans JE, Cresswell P (2009) Natural lipid ligands associated with human CD1d targeted to different subcellular compartments. J Immunol 182(8): 4784-4791.
41. Cox D, et al. (2009) Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 4(5):e5325.
42. Chang DH, et al. (2008) Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer. Blood 112(4):1308-1316.
43. Fox LM, et al. (2009) Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 7(10):e1000228.
44. Zeissig S, et al. (2012) Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 18(7):1060-1068.
45. Abe A, Shayman JA, Radin NS (1996) A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2-ceramides. J Biol Chem 271 (24):14383-14389.
46. 2 with transacylase activity. J Biol Chem 273(14): 8467-8474.
47. Hiraoka M, Abe A, Shayman JA (2002) Cloning and characterization of a lysosomal phospholipase A2, 1-O-acylceramide synthase. J Biol Chem 277(12):10090-10099.
48. Abe A, Hiraoka M, Shayman JA (2006) Positional specificity of lysosomal phospholipase A2. J Lipid Res 47(10):2268-2279.
49. Abe A, Hiraoka M, Shayman JA (2007) The acylation of lipophilic alcohols by lysosomal phospholipase A2. J Lipid Res 48(10):2255-2263.
50. 2 and phospholipidosis. Mol Cell Biol 26(16):6139-6148.
51. Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A (2005) Characterization of the early stages of thymic NKT cell development. J Exp Med 202(4):485-492.
52. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A (2002) A thymic precursor to the NK T cell lineage. Science 296(5567):553-555.
53. Florence WC, et al. (2009) Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. EMBO J 28(22):3579-3590.
54. Gui M, Li J, Wen LJ, Hardy RR, Hayakawa K (2001) TCR beta chain influences but does not solely control autoreactivity of V alpha 14J281T cells. J Immunol 167(11):6239-6246.
55. Prigozy TI, et al. (2001) Glycolipid antigen processing for presentation by CD1d molecules. Science 291(5504):664-667.
56. Gadola SD, et al. (2006) Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J Exp Med 203(10): 2293-2303.
57. Shayman JA, Kelly R, Kollmeyer J, He Y, Abe A (2011) Group XV phospholipase A2, a lysosomal phospholipase A2. Prog Lipid Res 50(1):1-13.
58. Pellicci DG, et al. (2003) Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide. Eur J Immunol 33(7):1816-1823.
59. McNab FW, et al. (2005) The influence of CD1d in postselection NKT cell maturation and homeostasis. J Immunol 175(6):3762-3768.
60. Schümann J, et al. (2007) Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur J Immunol 37(6):1431-1441.
61. Balreira A, et al. (2008) Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients. Br J Haematol 143(4):601-604.
62. Speak AO, et al. (2012) Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C. Eur J Immunol 42(7):1886-1892.
63. Pei B, et al. (2011) Diverse endogenous antigens for mouse NKT cells: Self-antigens that are not glycosphingolipids. J Immunol 186(3):1348-1360.
64. Fuller N, Rand RP (2001) The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes. Biophys J 81(1):243-254.
65. López-Sagaseta J, Sibener LV, Kung JE, Gumperz J, Adams EJ (2012) Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor. EMBO J 31(8):2047-2059.
66. Koch M, et al. (2005) The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol 6(8):819-826.
67. Sullivan BA, et al. (2010) Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. J Immunol 184(1):141-153.
68. Wu D, et al. (2006) Design of natural killer T cell activators: Structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci USA 103(11): 3972-3977.
69. Zajonc DM, et al. (2005) Structure and function of a potent agonist for the semiinvariant natural killer T cell receptor. Nat Immunol 6(8):810-818.
70. Schiefner A, Fujio M, Wu D, Wong CH, Wilson IA (2009) Structural evaluation of potent NKT cell agonists: Implications for design of novel stimulatory ligands. J Mol Biol 394(1):71-82.
71. 2 is selectively expressed in alveolar macrophages. J Biol Chem 279(41):42605-42611.
72. Cho YN, et al. (2011) Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: Their deficiency related to disease activity. Rheumatology (Oxford) 50(6):1054-1063.
73. Sawada H, Takami K, Asahi S (2005) A toxicogenomic approach to drug-induced phospholipidosis: Analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci 83(2):282-292.
74. 2 function. J Lipid Res 50(10):2027-2035.